Sequoia Financial Advisors LLC Buys New Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Sequoia Financial Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, Holdings Channel.com reports. The firm purchased 5,968 shares of the exchange traded fund’s stock, valued at approximately $533,000.

A number of other institutional investors also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC lifted its holdings in SPDR S&P Biotech ETF by 11.5% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 201,812 shares of the exchange traded fund’s stock worth $18,020,000 after buying an additional 20,734 shares during the last quarter. SOL Capital Management CO lifted its holdings in shares of SPDR S&P Biotech ETF by 134.2% in the 4th quarter. SOL Capital Management CO now owns 24,196 shares of the exchange traded fund’s stock valued at $2,160,000 after purchasing an additional 13,865 shares during the last quarter. HBK Sorce Advisory LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 6.4% in the 4th quarter. HBK Sorce Advisory LLC now owns 4,425 shares of the exchange traded fund’s stock valued at $395,000 after purchasing an additional 267 shares during the last quarter. International Assets Investment Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $10,587,000. Finally, United Capital Management of KS Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 1.8% in the 4th quarter. United Capital Management of KS Inc. now owns 104,048 shares of the exchange traded fund’s stock valued at $9,290,000 after purchasing an additional 1,831 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $85.62 on Wednesday. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52. The company has a market capitalization of $6.65 billion, a P/E ratio of 11.47 and a beta of 1.08. The stock has a 50-day simple moving average of $93.86 and a 200-day simple moving average of $84.12.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.